Invetech’s 3rd Generation Closed Filling System for Cell and Gene Therapy provides robust, cost-effective, ‘Good Manufacturing Practice’ (GMP) based commercial manufacturing systems for life-saving treatments such as Chimeric Antigen Receptor T-Cell (CAR-T) therapy (a new form of immunotherapy that uses specially altered T-cells to directly and precisely target cancer cells).